{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.25","value":"0.71"},{"groupId":"OG001","spread":"0.32","value":"0.82"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Kidney"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.43","value":"1.2"},{"groupId":"OG001","spread":"0.45","value":"1.0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Pituitary"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.0035","value":"0.024"},{"groupId":"OG001","spread":"0.0052","value":"0.028"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Red Marrow (Blood)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.018","value":"0.043"},{"groupId":"OG001","spread":"0.028","value":"0.067"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Red Marrow (Image)"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.39","value":"0.63"},{"groupId":"OG001","spread":"0.17","value":"0.82"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Spleen"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.034","value":"0.50"},{"groupId":"OG001","spread":"0.096","value":"0.59"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Urinary Bladder Wall"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.013","value":"0.040"},{"groupId":"OG001","spread":"0.0073","value":"0.041"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"title":"Total Body"}],"denoms":[{"counts":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"6"}],"units":"Participants"}],"description":"Absorbed radiation doses in target organ (e.g. kidney and bone marrow) was evaluated when all Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) and Pheochromocytoma and paraganglioma (PPGLs) as a pooled cohort patients had completed the 1st treatment of Lutathera and completed the dosimetry assessment.","dispersionType":"Standard Deviation","groups":[{"description":"All eligible participants with Gastroenteropancreatic neuroendocrine tumor (GEP-NET) received at least one dose of Lutathera (7.4 GBq/200 mCi x 4 administrations every 8+/-1 weeks; cumulative dose: 29.6 GBq/800 mCi), with a concomitant administration of 2.5% Lysine - Arginine amino acid solution.","id":"OG000","title":"GEP-NET"},{"description":"All eligible participants with Pheochromocytoma and paraganglioma (PPGL) received at least one dose of Lutathera (7.4 GBq/200 mCi x 4 administrations every 8+/-1 weeks; cumulative dose: 29.6 GBq/800 mCi), with a concomitant administration of 2.5% Lysine - Arginine amino acid solution.","id":"OG001","title":"PPGL"}],"paramType":"MEAN","populationDescription":"Dosimetry Analysis Set (DAS): The DAS consisted of all participants who had at least one valid (i.e., not flagged for exclusion by the dosimetrist) dosimetry measurement.","reportingStatus":"POSTED","timeFrame":"Up to 8 days after the first Lutetium [Lu 177] dotatate dose","title":"Absorbed Radiation Doses in Target Organ","type":"PRIMARY","unitOfMeasure":"Gy/GBq"}